Healthcare (Basel, Switzerland) · 2026
EHR-Based Advanced Care Planning and Late-Stage Cancer Treatment in a Middle-Income Country: A Retrospective Cohort Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Leal Matheus Hermes, Funk Rafaella, Camargo Laura Lima, Rego Francisca, Nunes Rui
Аннотация
BACKGROUND: Cancer-directed treatment near the end of life may represent low-value, high-intensity care and potential medical futility, but data from middle-income countries are limited. This study used digitally documented advanced care planning (ACP) in the electronic health record (EHR) and indicators of late oncologic interventions (LOI) within 15 and 30 days before death to examine end-of-life care in Brazil.
OBJECTIVE: To identify factors associated with LOI near death and to explore whether documented ACP is linked to lower treatment intensity.
DESIGN: Retrospective cohort study.
SETTING/PARTICIPANTS: Adults with metastatic solid tumors who died between January 2022 and December 2023 in two oncology referral hospitals in southern Brazil and had ≥6 months of premortem EHR data.
MEASUREMENTS: LOI were defined as systemic anticancer therapy, radiotherapy, or oncologic surgery within 30 days (LOI-30) or 15 days (LOI-15) before death. Independent predictors were estimated by Poisson regression with robust variance.
RESULTS: Among 79 patients, 21.5% received LOI-30 and 8.9% received LOI-15. Breast and lung cancers were the most common primary sites. LOI-30 was independently associated with age < 60 years (relative risk [RR] 3.76; 95% confidence interval [CI] 1.50-9.44), higher education (RR 2.07; 95% CI 1.07-3.99), and lower platelet count (RR 0.96 per 10,000/µL; 95% CI 0.92-0.99). ACP was documented for 19% of patients and was associated with absence of LOI-30.
CONCLUSIONS: Digitally visible ACP in the EHR was associated with reduced aggressive end-of-life care. Using existing EHR infrastructure to prompt and standardize ACP documentation may help align care with patient values in middle-income countries.
OBJECTIVE: To identify factors associated with LOI near death and to explore whether documented ACP is linked to lower treatment intensity.
DESIGN: Retrospective cohort study.
SETTING/PARTICIPANTS: Adults with metastatic solid tumors who died between January 2022 and December 2023 in two oncology referral hospitals in southern Brazil and had ≥6 months of premortem EHR data.
MEASUREMENTS: LOI were defined as systemic anticancer therapy, radiotherapy, or oncologic surgery within 30 days (LOI-30) or 15 days (LOI-15) before death. Independent predictors were estimated by Poisson regression with robust variance.
RESULTS: Among 79 patients, 21.5% received LOI-30 and 8.9% received LOI-15. Breast and lung cancers were the most common primary sites. LOI-30 was independently associated with age < 60 years (relative risk [RR] 3.76; 95% confidence interval [CI] 1.50-9.44), higher education (RR 2.07; 95% CI 1.07-3.99), and lower platelet count (RR 0.96 per 10,000/µL; 95% CI 0.92-0.99). ACP was documented for 19% of patients and was associated with absence of LOI-30.
CONCLUSIONS: Digitally visible ACP in the EHR was associated with reduced aggressive end-of-life care. Using existing EHR infrastructure to prompt and standardize ACP documentation may help align care with patient values in middle-income countries.